Molbio Diagnostics Ltd

NSE: MOLBIO · BSE: 544866 · Healthcare · 8 announcements

Share price: ₹1,246.00
Market cap: ₹14,359 Cr
Revenue (annual): ₹1,446 Cr
Net profit (annual): ₹166.6 Cr
Promoter holding: 41.29%
FII holding: 1.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 2 Earnings Call 2 Results Update 1 Financial Results 1 Capital Structure Change 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

12 Sep 2026 10:14 IST BSE

Earnings Call

Molbio Diagnostics Earnings Call Transcript: Key Takeaways

Molbio reported Q1 FY27 revenue of ₹408 Cr with a 25% EBITDA margin. Strategy focuses on expanding Truenat's global footprint and integrating digital pathology via OptraScan.

Call: Guides 25% growth

Open call summary → Read the filing ↗

8 Sep 2026 14:52 IST NSE

Earnings Call

Molbio Diagnostics Investor Presentation: Key Takeaways

Molbio Diagnostics listed on Aug 17, 2026. Q1 FY27 saw Total Income of ₹411.5 Cr and EBITDA of ₹103.7 Cr, transitioning from a loss in Q1 FY26 driven by higher test-kit consumption.

Open call summary → Read the filing ↗